Dartmouth Cancer Center (DCC) announced that Edward Kaftan, PhD, will join the organization as the associate director for administration and scientific affairs.
Kaftan will have lead responsibility at Dartmouth for Cancer Center research administration and its role in fulfilling the Center’s National Cancer Institute (NCI) designation as a Comprehensive Cancer Center. He will serve on DCC senior leadership and direct the administrative team supporting cancer research initiatives.
His responsibilities will include advancing faculty collaborations across four cancer-related, multidisciplinary programs; overseeing access to clinical trials, shared research resources and developmental funding; supporting cancer research education and training; and community outreach and engagement.
Kaftan comes to Dartmouth most recently from Yale Cancer Center, where he served as associate director for administration. He brings more than 20 years of experience in biomedical research and drug discovery.
At DCC, Kaftan succeeds Robert Gerlach, MPA, who is retiring after 19 years at DCC. Gerlach’s more than 50-year career spanned eight NCI Comprehensive Cancer Center designations, including his work supporting the initial recognition of new centers in Buffalo, New York and Cleveland, Ohio.
Kaftan will begin his new role on October 1.
About Dartmouth Cancer Center
Since 1972, Dartmouth Cancer Center (DCC) has combined groundbreaking and advanced cancer research at Dartmouth and the Geisel School of Medicine with award-winning, personalized, compassionate, patient-centered cancer care and clinical trials. At its flagship location at Dartmouth Health’s Dartmouth Hitchcock Medical Center, with 14 locations across New Hampshire and Vermont, DCC is one of fewer than 60 National Cancer Institute-designated Comprehensive Cancer Centers nationally. Each year, DCC manages 74,000 appointments, treats more than 4,500 newly diagnosed patients, and currently offers more than 240 active clinical trials. DCC remains committed to excellence, outreach and education. DCC strives to create new knowledge and impact, accelerate integrated and collaborative research to prevent and cure cancer, enhance survivorship and promote cancer-related health equity. Learn more at cancer.dartmouth.edu.